Dihydroergotamine Mesylate and Insulin glargine
Determining the interaction of Dihydroergotamine Mesylate and Insulin glargine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Insulin Glargine (U-100) Cartridge Systems and Pens
- Dihydroergotamine Mesylate-Insulin Glargine (U-100) Vials
- Dihydroergotamine Mesylate-Insulin Glargine (U-300) Pens
- Dihydroergotamine Mesylate-Insulin glargine and lixisenatide
- Dihydroergotamine Mesylate-Insulin glargine and lixisenatide Subcutaneous
- Dihydroergotamine Mesylate-Insulin glargine, recombinant Subcutaneous
- Insulin glargine-Dihydroergotamine nasal
- Insulin glargine-Dihydroergotamine Nasal Spray
- Insulin glargine-Dilacor XR
- Insulin glargine-Dilantin
- Insulin glargine-Dilantin Infatabs
- Insulin glargine-Dilantin injection